Mengbo Hu

3PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 21, 2023
Correction to: Prevalence of tumour-infiltrating CD103+ cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome.

Quan Zhou, Yuxi Ou, Xiyu Dai

|Feb 09, 2023
Prevalence of tumour-infiltrating CD103+ cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome.

Quan Zhou, Yuxi Ou, Xiyu Dai

|Jan 08, 2018
Prognostic factors in Chinese patients with prostate cancer receiving primary androgen deprivation therapy: validation of Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score and impacts of pre-existing obesity and diabetes mellitus.

Meng-Bo Hu, Tian Yang, Ji-Meng Hu

Pageof 1

Frequent Collaborators

2 joint publications

Chen Yang

2 joint publications

Limin Zhang

2 joint publications

Haowen Jiang